BSX · Boston Scientific Corp · Debt
$45.78
-0.24 (-0.51%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$66.68B
Shares
1.45B
Volume · Oct 23
6.37M
Avg daily vol (3M)
19.61M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current debt and lease obligations | 2026-06-30 | USD 1,709,000,000 | 10-Q filed 2026-08-03 |
| Noncurrent long-term debt and lease obligations | 2026-06-30 | USD 10,915,000,000 | 10-Q filed 2026-08-03 |
7 filing observations remain unmatched and are excluded from instrument histories.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
2 filings have incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
885725
CUSIP
101137107
13F (30d)
333 filings
315 filers
Visit website
Investor relations